Notable Analyst Upgrades and Downgrades for Week of January 17 2022

 

Upgrades:

 

Brookfield Renewable Partners (TSE:BEP.UN) (NYSE:BEP) was upgraded by investment analysts at National Bankshares to a "buy" rating in a report issued on Tuesday, TipRanks reports. The firm currently has a C$38.00 price target on the stock. National Bankshares' target price indicates a potential downside of 8.21% from the company's previous close.

BEP.UN has been the subject of a number of other research reports. Tudor Pickering & Holt set a C$44.00 price objective on shares of Brookfield Renewable Partners and gave the company a "buy" rating in a research report on Monday, November 8th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a C$45.00 price objective on shares of Brookfield Renewable Partners in a research report on Monday, September 20th. JPMorgan Chase & Co. raised shares of Brookfield Renewable Partners to a "buy" rating and set a C$46.00 price target for the company in a research report on Thursday, December 9th. Scotiabank raised shares of Brookfield Renewable Partners to a "buy" rating in a research report on Friday, January 7th. Finally, Tudor Pickering reissued a "buy" rating and issued a C$44.00 price target on shares of Brookfield Renewable Partners in a research report on Wednesday, September 22nd. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, Brookfield Renewable Partners presently has a consensus rating of "Buy" and a consensus target price of C$44.38. Read more …

 

ConocoPhillips (NYSE:COP) was upgraded by equities researchers at The Goldman Sachs Group to a "buy" rating in a research note issued to investors on Tuesday, Stock Target Advisor reports. The brokerage presently has a $101.00 target price on the energy producer's stock. The Goldman Sachs Group's price objective suggests a potential upside of 16.44% from the stock's current price.

A number of other equities research analysts have also issued reports on the stock. Truist raised their price target on shares of ConocoPhillips from $100.00 to $111.00 in a report on Friday. KeyCorp raised their target price on ConocoPhillips from $81.00 to $88.00 and gave the stock an "overweight" rating in a research note on Thursday, January 13th. Societe Generale lowered ConocoPhillips from a "buy" rating to a "hold" rating and set a $77.00 price target for the company. in a research report on Wednesday, November 10th. Morgan Stanley lifted their price objective on ConocoPhillips from $90.00 to $95.00 and gave the stock an "overweight" rating in a research report on Friday, November 19th. Finally, Raymond James boosted their target price on ConocoPhillips from $90.00 to $100.00 and gave the company a "strong-buy" rating in a research note on Tuesday, October 26th. Four equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of $84.35. Read more …

 

ABB (NYSE:ABB) was upgraded by Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a note issued to investors on Wednesday, The Fly reports.

Other analysts also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of ABB from CHF 31 to CHF 32 in a research note on Thursday, January 13th. JPMorgan Chase & Co. reaffirmed a "neutral" rating on shares of ABB in a research note on Friday, October 1st. Zacks Investment Research downgraded shares of ABB from a "hold" rating to a "strong sell" rating and set a $33.00 price target for the company. in a research note on Tuesday, January 4th. Morgan Stanley reaffirmed an "underweight" rating on shares of ABB in a research note on Friday, October 22nd. Finally, Exane BNP Paribas raised shares of ABB to a "neutral" rating and set a CHF 37 price objective on the stock in a report on Tuesday, September 21st. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $35.55. Read more …

 

 

Bank of Montreal (NYSE:BMO) (TSE:BMO) was upgraded by Barclays to an "overweight" rating in a research report issued to clients and investors on Wednesday, Stock Target Advisor reports. The brokerage presently has a $165.00 price objective on the bank's stock, up from their prior price objective of $140.00. Barclays's target price points to a potential upside of 39.19% from the stock's previous close.

Other analysts have also recently issued research reports about the company. Desjardins increased their target price on Bank of Montreal from C$146.00 to C$150.00 and gave the stock a "buy" rating in a report on Tuesday, December 7th. TD Securities increased their target price on Bank of Montreal from $150.00 to $155.00 and gave the stock a "buy" rating in a report on Monday, December 6th. Royal Bank of Canada upgraded Bank of Montreal from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $154.00 to $160.00 in a report on Tuesday, December 21st. Scotiabank cut Bank of Montreal from a "sector outperform" rating to a "sector perform" rating in a report on Tuesday, December 21st. Finally, Zacks Investment Research cut Bank of Montreal from a "buy" rating to a "hold" rating in a report on Tuesday, December 7th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, Bank of Montreal currently has an average rating of "Buy" and an average target price of $151.67. Read more …

Dividend Increases Week 50, 2021

 

In this article, I will go through the weekly dividend increases and cuts in popular and well-known stocks. (Member of The Dividend Champions or Canadian All-Star list)

 

Recently, 17 companies announced dividend increases. Note that no dividend cuts or suspensions were announced during this period.

 

The table below summarises the dividend change announcements.  The table shows the current dividend, the new dividend and the percentage increase (%). Dividends are shown on an annual basis and in US dollars unless otherwise stated. Yield is the new dividend yield of the most recent price, and Years is the years of consecutive dividend increases.

 

 

Notable Analyst Upgrades and Downgrades for Week of October 11, 2021

 

Upgrades:

 

C.H. Robinson Worldwide (NASDAQ:CHRW) was upgraded by equities researchers at Vertical Research from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Monday, PriceTargets.com reports.

A number of other research firms also recently issued reports on CHRW. Evercore ISI began coverage on shares of C.H. Robinson Worldwide in a research note on Monday, September 13th. They issued an "inline" rating and a $95.00 price target for the company. Morgan Stanley increased their price target on shares of C.H. Robinson Worldwide from $58.00 to $60.00 and gave the stock an "underweight" rating in a research note on Thursday, July 8th. Wells Fargo & Company decreased their price target on shares of C.H. Robinson Worldwide from $95.00 to $90.00 and set an "underweight" rating for the company in a research note on Tuesday, July 13th. Zacks Investment Research downgraded shares of C.H. Robinson Worldwide from a "buy" rating to a "hold" rating and set a $94.00 price target for the company. in a research note on Monday, August 2nd. Finally, Citigroup decreased their price target on shares of C.H. Robinson Worldwide from $118.00 to $115.00 and set a "buy" rating for the company in a research note on Wednesday, July 14th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $98.31. Read more …

 

Eli Lilly and (NYSE:LLY) was upgraded by stock analysts at Berenberg Bank from a "hold" rating to a "buy" rating in a research note issued to investors on Monday, The Fly reports.

A number of other equities research analysts have also recently commented on LLY. Truist assumed coverage on Eli Lilly and in a research note on Tuesday, July 27th. They set a "buy" rating and a $262.00 target price on the stock. DZ Bank upgraded Eli Lilly and from a "hold" rating to a "buy" rating and set a $288.00 price objective on the stock in a research note on Thursday, August 5th. Mizuho boosted their price objective on Eli Lilly and from $250.00 to $279.00 and gave the company a "buy" rating in a research note on Wednesday, August 4th. Truist Securities upped their price target on Eli Lilly and from $225.00 to $262.00 and gave the company a "buy" rating in a research report on Friday, July 2nd. Finally, The Goldman Sachs Group upped their price target on Eli Lilly and from $252.00 to $270.00 and gave the company a "conviction-buy" rating in a research report on Monday, June 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Eli Lilly and presently has a consensus rating of "Buy" and a consensus target price of $257.53. Read more …

 

3M (NYSE:MMM) was upgraded by stock analysts at Langenberg & Company from a “hold” rating to a “buy” rating in a research report issued on Monday, The Fly reports.

Several other equities analysts also recently weighed in on MMM. Wolfe Research downgraded 3M from a “peer perform” rating to an “underperform” rating and dropped their price objective for the company from $218.00 to $215.00 in a research note on Monday, July 12th. Credit Suisse Group downgraded 3M from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $210.00 to $212.00 in a research note on Tuesday, July 6th. Zacks Investment Research raised 3M from a “hold” rating to a “buy” rating and set a $208.00 price objective for the company in a research note on Friday, August 6th. JPMorgan Chase & Co. downgraded 3M from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $215.00 to $210.00 in a research report on Monday, October 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on 3M from $196.00 to $201.00 and gave the stock a “hold” rating in a research report on Wednesday, July 28th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $196.54. Read more …

 

 

Starbucks (NASDAQ:SBUX) was upgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note issued on Monday, The Fly reports.

A number of other research firms also recently issued reports on SBUX. Barclays raised their price target on shares of Starbucks from $140.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 28th. Wells Fargo & Company assumed coverage on shares of Starbucks in a research report on Sunday, June 20th. They issued a “buy” rating on the stock. Cowen lifted their price objective on shares of Starbucks from $126.00 to $135.00 and gave the company an “outperform” rating in a research report on Wednesday, July 28th. BMO Capital Markets lifted their price objective on shares of Starbucks from $125.00 to $140.00 and gave the company an “outperform” rating in a research report on Wednesday, July 28th. Finally, Jefferies Financial Group lifted their price objective on shares of Starbucks from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Wednesday, July 28th. Eight equities research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $126.96. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of September 27, 2021

 

Upgrades:

 

Sanofi (NASDAQ:SNY) was upgraded by SVB Leerink from a “market perform” rating to an “outperform” rating in a report issued on Monday, Analyst Price Targets reports.

Several other equities research analysts have also recently weighed in on SNY. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Sanofi in a report on Friday, July 30th. Morgan Stanley reissued an “overweight” rating on shares of Sanofi in a report on Friday, August 6th. Finally, UBS Group reiterated a “buy” rating on shares of Sanofi in a research report on Thursday, August 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $53.00. Read more …

 

The Western Union (NYSE:WU) was upgraded by equities researchers at Citigroup from a “neutral” rating to a “buy” rating in a report issued on Monday, The Fly reports.

NYSE WU opened at $20.23 on Monday. The stock has a fifty day moving average of $21.94 and a 200-day moving average of $23.70. The stock has a market capitalization of $8.22 billion, a P/E ratio of 10.32 and a beta of 0.99. The Western Union has a 52 week low of $19.07 and a 52 week high of $26.61. The company has a debt-to-equity ratio of 10.47, a quick ratio of 0.94 and a current ratio of 0.94. Read more …

 

Eli Lilly and (NYSE:LLY) was upgraded by equities researchers at Citigroup from a "neutral" rating to a "buy" rating in a note issued to investors on Wednesday, The Fly reports. The brokerage presently has a $265.00 price target on the stock, up from their prior price target of $210.00. Citigroup's price objective indicates a potential upside of 19.58% from the company's current price. The analysts noted that the move was a valuation call.

LLY has been the topic of several other research reports. Barclays upped their target price on shares of Eli Lilly and from $227.00 to $250.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 6th. The Goldman Sachs Group upped their target price on shares of Eli Lilly and from $252.00 to $270.00 and gave the stock a "conviction-buy" rating in a research note on Monday, June 14th. Cantor Fitzgerald increased their price objective on shares of Eli Lilly and from $245.00 to $300.00 and gave the company an "overweight" rating in a research report on Thursday, June 24th. Read more …

 

 

UBS Group (NYSE:UBS) was upgraded by research analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a report issued on Wednesday, The Fly reports.

Other research analysts also recently issued reports about the company. Credit Suisse Group reaffirmed an "outperform" rating on shares of UBS Group in a report on Wednesday, July 21st. Morgan Stanley reaffirmed a "hold" rating on shares of UBS Group in a report on Tuesday, August 10th. Barclays reaffirmed an "underweight" rating on shares of UBS Group in a report on Monday, July 19th. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of UBS Group in a report on Wednesday, July 21st. Finally, The Goldman Sachs Group set a $15.80 target price on UBS Group and gave the stock a "hold" rating in a report on Thursday, July 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $15.70. Read more …

Notable Analyst Upgrades and Downgrades for Week of August 2, 2021

 

Upgrades:

 

AllianceBernstein (NYSE:AB) was upgraded by investment analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued on Monday, The Fly reports. The brokerage presently has a $54.50 target price on the asset manager’s stock, up from their prior target price of $44.00. Citigroup’s price objective points to a potential upside of 12.91% from the company’s current price.

Several other equities research analysts also recently issued reports on the stock. Sanford C. Bernstein downgraded shares of AllianceBernstein from a “buy” rating to a “neutral” rating in a research report on Friday, April 9th. Keefe, Bruyette & Woods restated a “market perform” rating and set a $42.00 target price on shares of AllianceBernstein in a report on Tuesday, April 13th. Zacks Investment Research cut shares of AllianceBernstein from a “buy” rating to a “hold” rating in a report on Tuesday, July 27th. Finally, Bank of America restated a “neutral” rating and set a $42.00 target price on shares of AllianceBernstein in a report on Thursday, April 15th. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. AllianceBernstein currently has an average rating of “Hold” and a consensus price target of $44.36. Read more …

 

Welltower (NYSE:WELL) was upgraded by equities research analysts at Berenberg Bank from a "hold" rating to a "buy" rating in a note issued to investors on Tuesday, The Fly reports. The brokerage currently has a $100.00 price objective on the real estate investment trust's stock. Berenberg Bank's target price indicates a potential upside of 15.92% from the stock's previous close.

Other equities analysts also recently issued research reports about the company. Wells Fargo & Company boosted their price target on Welltower from $78.00 to $89.00 and gave the stock an "equal weight" rating in a research report on Friday, July 23rd. Mizuho began coverage on Welltower in a research report on Wednesday, July 14th. They set a "neutral" rating and a $68.00 price target on the stock. Morgan Stanley boosted their price target on Welltower from $79.00 to $86.00 and gave the stock an "overweight" rating in a research report on Monday, July 26th. Capital One Financial raised Welltower from an "equal weight" rating to an "overweight" rating in a research report on Friday, May 21st. Finally, Wolfe Research began coverage on Welltower in a research report on Monday, June 14th. They set an "outperform" rating and a $94.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of "Buy" and a consensus price target of $79.67. Read more …

 

Simon Property Group (NYSE:SPG) was upgraded by equities researchers at Bank of America from a "neutral" rating to a "buy" rating in a note issued to investors on Wednesday, The Fly reports.

Several other brokerages have also recently weighed in on SPG. Truist Securities boosted their price objective on Simon Property Group from $102.00 to $130.00 and gave the stock a "hold" rating in a report on Wednesday, June 23rd. UBS Group assumed coverage on Simon Property Group in a report on Thursday, June 3rd. They set a "neutral" rating and a $135.00 price objective for the company. BMO Capital Markets reissued a "hold" rating on shares of Simon Property Group in a report on Thursday, May 20th. Truist upped their price target on Simon Property Group from $102.00 to $130.00 and gave the company a "hold" rating in a research note on Wednesday, June 23rd. Finally, Stifel Nicolaus raised Simon Property Group from a "hold" rating to a "buy" rating and upped their price target for the company from $125.00 to $132.00 in a research note on Monday, July 19th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have issued a buy rating to the company. Simon Property Group has an average rating of "Hold" and an average price target of $128.13. Read more …

 

 

Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at DNB Markets from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, The Fly reports.

NVO has been the topic of a number of other reports. Barclays reiterated an “overweight” rating on shares of Novo Nordisk A/S in a report on Monday, July 19th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Novo Nordisk A/S in a report on Tuesday. Finally, Zacks Investment Research upgraded shares of Novo Nordisk A/S from a “sell” rating to a “hold” rating and set a $91.00 price target on the stock in a report on Tuesday, July 13th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. Novo Nordisk A/S currently has a consensus rating of “Hold” and a consensus price target of $91.00. Read more …

Week's Most Significant Insider Trades: Week of September 23, 2019

Disposals:

Chubb Ltd (NYSE:CB) EVP Joseph F. Wayland sold 6,500 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $158.05, for a total transaction of $1,027,325.00. Following the sale, the executive vice president now directly owns 77,201 shares in the company, valued at $12,201,618.05. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

CB opened at $158.84 on Wednesday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.32 and a current ratio of 0.32. The stock has a market capitalization of $71.86 billion, a P/E ratio of 16.83, a P/E/G ratio of 1.52 and a beta of 0.69. The company’s 50-day simple moving average is $157.07 and its two-hundred day simple moving average is $147.59. Chubb Ltd has a 52-week low of $119.54 and a 52-week high of $162.19. Read more …

Eli Lilly And Co (NYSE:LLY) SVP Alfonso G. Zulueta sold 4,500 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $117.00, for a total value of $526,500.00. Following the completion of the sale, the senior vice president now owns 33,806 shares of the company’s stock, valued at $3,955,302. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

LLY opened at $113.25 on Wednesday. Eli Lilly And Co has a one year low of $104.17 and a one year high of $132.13. The stock has a market capitalization of $109.62 billion, a PE ratio of 20.41, a P/E/G ratio of 2.01 and a beta of 0.16. The business’s 50 day moving average price is $112.34 and its 200 day moving average price is $116.13. The company has a debt-to-equity ratio of 4.98, a quick ratio of 0.87 and a current ratio of 1.13. Read more …

Ross Stores, Inc. (NASDAQ:ROST) insider James S. Fassio sold 15,000 shares of the business’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $108.66, for a total value of $1,629,900.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

James S. Fassio also recently made the following trade(s):

On Friday, July 12th, James S. Fassio sold 85,238 shares of Ross Stores stock. The shares were sold at an average price of $104.85, for a total value of $8,937,204.30.

Shares of ROST stock opened at $107.03 on Tuesday. Ross Stores, Inc. has a 12-month low of $75.91 and a 12-month high of $110.88. The company has a current ratio of 1.31, a quick ratio of 0.63 and a debt-to-equity ratio of 0.85. The stock’s 50-day moving average price is $105.80 and its 200-day moving average price is $99.97. The stock has a market capitalization of $39.29 billion, a price-to-earnings ratio of 25.12, a price-to-earnings-growth ratio of 2.30 and a beta of 0.84. Read more …

Omega Healthcare Investors Inc (NYSE:OHI) CAO Michael Ritz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, September 25th. The stock was sold at an average price of $42.00, for a total value of $105,000.00. Following the transaction, the chief accounting officer now owns 5,485 shares in the company, valued at approximately $230,370. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Michael Ritz also recently made the following trade(s):

On Friday, August 23rd, Michael Ritz sold 5,000 shares of Omega Healthcare Investors stock. The stock was sold at an average price of $40.50, for a total value of $202,500.00.

NYSE:OHI opened at $42.01 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78. Omega Healthcare Investors Inc has a one year low of $31.69 and a one year high of $42.25. The business’s 50-day simple moving average is $40.23 and its 200 day simple moving average is $37.57. The stock has a market cap of $9.01 billion, a price-to-earnings ratio of 13.82, a price-to-earnings-growth ratio of 5.47 and a beta of 0.37. Read more …

Darden Restaurants, Inc. (NYSE:DRI) SVP Douglas J. Milanes sold 1,600 shares of the stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $119.05, for a total transaction of $190,480.00. Following the transaction, the senior vice president now directly owns 6,793 shares in the company, valued at approximately $808,706.65. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of NYSE DRI opened at $116.44 on Friday. Darden Restaurants, Inc. has a 1 year low of $95.83 and a 1 year high of $128.41. The stock has a market cap of $14.50 billion, a P/E ratio of 20.01, a price-to-earnings-growth ratio of 2.08 and a beta of 0.34. The firm has a 50-day moving average of $121.60 and a 200 day moving average of $119.95. The company has a debt-to-equity ratio of 2.18, a current ratio of 0.43 and a quick ratio of 0.30. Read more …

Acquisitions:

Nothing to mention!

Week's Most Significant Insider Trades: Week of September 9, 2019

Acquisitions:

Halliburton (NYSE:HAL) Director William E. Albrecht purchased 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average price of $19.35 per share, with a total value of $154,800.00. Following the transaction, the director now directly owns 16,000 shares in the company, valued at $309,600. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shares of Halliburton stock opened at $19.75 on Friday. The firm has a market cap of $17.54 billion, a price-to-earnings ratio of 10.39, a P/E/G ratio of 2.37 and a beta of 1.37. The company has a debt-to-equity ratio of 1.16, a current ratio of 2.26 and a quick ratio of 1.59. Halliburton has a 52-week low of $16.97 and a 52-week high of $42.57. The stock has a 50-day simple moving average of $19.77 and a 200-day simple moving average of $24.65. Read more …

Keurig Dr Pepper Inc (NYSE:KDP) insider Mary Beth Denooyer acquired 6,000 shares of the stock in a transaction dated Tuesday, September 10th. The stock was acquired at an average cost of $26.97 per share, with a total value of $161,820.00. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Mary Beth Denooyer also recently made the following trade(s):

On Tuesday, September 3rd, Mary Beth Denooyer acquired 6,000 shares of Keurig Dr Pepper stock. The stock was acquired at an average cost of $26.85 per share, with a total value of $161,100.00.

On Tuesday, August 27th, Mary Beth Denooyer acquired 6,000 shares of Keurig Dr Pepper stock. The stock was acquired at an average cost of $26.78 per share, with a total value of $160,680.00.

On Tuesday, August 20th, Mary Beth Denooyer acquired 6,000 shares of Keurig Dr Pepper stock. The stock was acquired at an average cost of $27.99 per share, with a total value of $167,940.00.

Shares of Keurig Dr Pepper stock opened at $27.66 on Friday. Keurig Dr Pepper Inc has a 52-week low of $22.19 and a 52-week high of $31.06. The company has a 50 day moving average of $27.69 and a 200 day moving average of $28.09. The company has a quick ratio of 0.23, a current ratio of 0.33 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $38.21 billion, a P/E ratio of 26.60, a P/E/G ratio of 1.45 and a beta of 0.45. Read more …

Disposals:

Eli Lilly And Co (NYSE:LLY) SVP Stephen F. Fry sold 9,452 shares of the business’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $115.00, for a total transaction of $1,086,980.00. Following the completion of the transaction, the senior vice president now owns 100,211 shares of the company’s stock, valued at approximately $11,524,265. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Eli Lilly And Co stock opened at $111.07 on Tuesday. The company has a current ratio of 1.13, a quick ratio of 0.87 and a debt-to-equity ratio of 4.98. The company has a fifty day simple moving average of $111.39 and a 200-day simple moving average of $117.06. The stock has a market cap of $110.64 billion, a P/E ratio of 20.01, a price-to-earnings-growth ratio of 2.03 and a beta of 0.16. Eli Lilly And Co has a 12-month low of $104.17 and a 12-month high of $132.13. Read more …

Mondelez International Inc (NASDAQ:MDLZ) EVP Vinzenz P. Gruber sold 40,377 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $56.68, for a total value of $2,288,568.36. Following the transaction, the executive vice president now owns 112,137 shares in the company, valued at $6,355,925.16. The sale was disclosed in a document filed with the SEC, which is available at this link.

MDLZ stock opened at $56.48 on Tuesday. The stock has a market cap of $80.96 billion, a P/E ratio of 23.24, a P/E/G ratio of 2.94 and a beta of 0.82. The company has a current ratio of 0.44, a quick ratio of 0.29 and a debt-to-equity ratio of 0.47. The stock’s fifty day simple moving average is $54.63 and its two-hundred day simple moving average is $52.17. Mondelez International Inc has a 1-year low of $38.78 and a 1-year high of $56.72. Read more …

Week's Most Significant Insider Trades: Week of September 2, 2019

Acquisitions:

AbbVie Inc (NYSE:ABBV) SVP Nicholas Donoghoe purchased 7,525 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were purchased at an average cost of $66.19 per share, with a total value of $498,079.75. Following the purchase, the senior vice president now directly owns 13,090 shares in the company, valued at $866,427.10. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of ABBV stock opened at $67.03 on Friday. The firm has a 50-day moving average price of $66.18 and a 200 day moving average price of $75.18. AbbVie Inc has a twelve month low of $62.66 and a twelve month high of $96.60. The company has a market capitalization of $98.14 billion, a price-to-earnings ratio of 8.47, a PEG ratio of 1.58 and a beta of 0.95. Read more …

Intel Co. (NASDAQ:INTC) CEO Robert Holmes Swan acquired 10,918 shares of Intel stock in a transaction dated Wednesday, August 28th. The shares were acquired at an average price of $45.70 per share, with a total value of $498,952.60. Following the transaction, the chief executive officer now owns 168,955 shares in the company, valued at approximately $7,721,243.50. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Read more …

Intel Co. (NASDAQ:INTC) CFO George S. Davis acquired 5,458 shares of Intel stock in a transaction on Wednesday, August 28th. The stock was purchased at an average price of $45.70 per share, with a total value of $249,430.60. Following the transaction, the chief financial officer now directly owns 13,276 shares in the company, valued at approximately $606,713.20. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

INTC stock opened at $49.84 on Thursday. The business has a fifty day moving average price of $48.13 and a 200 day moving average price of $49.91. Intel Co. has a fifty-two week low of $42.36 and a fifty-two week high of $59.59. The stock has a market capitalization of $208.12 billion, a price-to-earnings ratio of 10.68, a P/E/G ratio of 1.43 and a beta of 0.90. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.48 and a quick ratio of 1.04. Read more …

UnitedHealth Group Inc (NYSE:UNH) Director Timothy Patrick Flynn purchased 2,000 shares of the business’s stock in a transaction dated Wednesday, August 28th. The shares were purchased at an average cost of $227.55 per share, with a total value of $455,100.00. Following the completion of the purchase, the director now directly owns 5,524 shares in the company, valued at $1,256,986.20. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of UNH stock opened at $229.59 on Friday. The stock’s 50 day simple moving average is $244.08 and its 200 day simple moving average is $244.79. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a market capitalization of $217.58 billion, a price-to-earnings ratio of 17.83, a PEG ratio of 1.23 and a beta of 0.62. Read more …

Keurig Dr Pepper Inc (NYSE:KDP) insider Mary Beth Denooyer purchased 6,000 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were purchased at an average price of $26.78 per share, with a total value of $160,680.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Mary Beth Denooyer also recently made the following trade(s):

On Tuesday, September 3rd, Mary Beth Denooyer bought 6,000 shares of Keurig Dr Pepper stock. The stock was bought at an average price of $26.85 per share, with a total value of $161,100.00.

On Tuesday, August 20th, Mary Beth Denooyer bought 6,000 shares of Keurig Dr Pepper stock. The stock was bought at an average price of $27.99 per share, with a total value of $167,940.00.

Shares of NYSE KDP traded down $0.13 during midday trading on Friday, reaching $27.02. 46,138 shares of the stock were exchanged, compared to its average volume of 2,134,656. The company has a market capitalization of $37.98 billion, a price-to-earnings ratio of 26.14, a P/E/G ratio of 1.44 and a beta of 0.45. Keurig Dr Pepper Inc has a 12 month low of $22.19 and a 12 month high of $31.06. The business has a 50-day simple moving average of $27.77 and a two-hundred day simple moving average of $28.12. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.33 and a quick ratio of 0.23. Read more …

Week's Most Significant Insider Trades: Week of February 18, 2019

Acquisitions:

Kinder Morgan Inc (NYSE:KMI) insider Richard D. Kinder acquired 200,000 shares of the company’s stock in a transaction that occurred on Friday, February 15th. The shares were bought at an average cost of $18.93 per share, for a total transaction of $3,786,000.00. Following the acquisition, the insider now directly owns 236,692,545 shares in the company, valued at approximately $4,480,589,876.85. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.  Read more …

Kinder Morgan Inc (NYSE:KMI) insider Richard D. Kinder bought 300,000 shares of the business’s stock in a transaction on Thursday, February 21st. The stock was bought at an average cost of $19.15 per share, for a total transaction of $5,745,000.00. Following the purchase, the insider now directly owns 237,011,657 shares of the company’s stock, valued at approximately $4,538,773,231.55. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. KMI stock traded up $0.18 during trading on Friday, reaching $19.37. 8,769,645 shares of the stock were exchanged, compared to its average volume of 13,353,239. The company has a debt-to-equity ratio of 0.98, a current ratio of 0.76 and a quick ratio of 0.71. Kinder Morgan Inc has a 1 year low of $14.62 and a 1 year high of $19.32. The company has a market capitalization of $42.29 billion, a PE ratio of 21.76, a price-to-earnings-growth ratio of 2.57 and a beta of 0.89. Read more …

Invesco Ltd. (NYSE:IVZ) Director Rod Canion acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 21st. The shares were bought at an average cost of $18.89 per share, for a total transaction of $377,800.00. Following the acquisition, the director now owns 84,451 shares of the company’s stock, valued at approximately $1,595,279.39. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Rod Canion also recently made the following trade(s):

On Friday, February 8th, Rod Canion acquired 10,000 shares of Invesco stock. The shares were bought at an average cost of $17.97 per share, for a total transaction of $179,700.00.

Shares of NYSE IVZ traded up $0.22 on Friday, hitting $19.05. The company’s stock had a trading volume of 3,319,160 shares, compared to its average volume of 4,720,450. Invesco Ltd. has a 12-month low of $15.38 and a 12-month high of $35.03. The company has a market capitalization of $7.83 billion, a PE ratio of 7.84, a price-to-earnings-growth ratio of 1.15 and a beta of 1.50. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.55 and a quick ratio of 1.55. Read more …

Disposals:

3M Co (NYSE:MMM) EVP Joaquin Delgado sold 4,897 shares of the firm’s stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $207.30, for a total value of $1,015,148.10. Following the transaction, the executive vice president now owns 23,191 shares of the company’s stock, valued at approximately $4,807,494.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Shares of MMM traded down $0.92 during trading hours on Tuesday, reaching $207.94. 48,139 shares of the company traded hands, compared to its average volume of 2,365,593. The firm has a market capitalization of $120.26 billion, a PE ratio of 19.89, a price-to-earnings-growth ratio of 1.93 and a beta of 1.06. 3M Co has a 12-month low of $176.87 and a 12-month high of $244.86. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.89 and a quick ratio of 1.29. Read more …

Week's Most Significant Insider Trades: Week of December 10, 2018

Disposals:

Ventas, Inc. (NYSE:VTR) EVP T Richard Riney sold 15,676 shares of Ventas stock in a transaction dated Thursday, December 6th. The stock was sold at an average price of $65.00, for a total transaction of $1,018,940.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

T Richard Riney also recently made the following trade(s):

On Tuesday, November 20th, T Richard Riney sold 15,288 shares of Ventas stock. The stock was sold at an average price of $62.50, for a total transaction of $955,500.00.

Shares of Ventas stock opened at $63.13 on Thursday. Ventas, Inc. has a twelve month low of $46.55 and a twelve month high of $65.70. The company has a quick ratio of 0.56, a current ratio of 0.56 and a debt-to-equity ratio of 1.00. The stock has a market capitalization of $23.34 billion, a price-to-earnings ratio of 15.18, a price-to-earnings-growth ratio of 4.85 and a beta of 0.06. Read more …

Comcast Co. (NASDAQ:CMCSA) Director Kenneth J. Bacon sold 7,636 shares of the company’s stock in a transaction that occurred on Monday, December 10th. The stock was sold at an average price of $37.04, for a total transaction of $282,837.44. Following the completion of the transaction, the director now owns 33,603 shares of the company’s stock, valued at $1,244,655.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Comcast stock traded down $0.50 during mid-day trading on Tuesday, reaching $36.85. 2,059,890 shares of the company’s stock traded hands, compared to its average volume of 18,604,142. The company has a market cap of $173.75 billion, a price-to-earnings ratio of 17.96, a PEG ratio of 1.18 and a beta of 0.92. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.96. Comcast Co. has a 12-month low of $30.43 and a 12-month high of $44.00. Read more …

Microsoft Co. (NASDAQ:MSFT) EVP Christopher C. Capossela sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, December 10th. The shares were sold at an average price of $105.50, for a total value of $422,000.00. Following the sale, the executive vice president now owns 169,931 shares of the company’s stock, valued at approximately $17,927,720.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Shares of NASDAQ:MSFT opened at $108.59 on Wednesday. The firm has a market capitalization of $807.09 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 1.90 and a beta of 1.25. The company has a quick ratio of 2.85, a current ratio of 2.92 and a debt-to-equity ratio of 0.88. Microsoft Co. has a 1 year low of $83.83 and a 1 year high of $116.18. Read more …

Eli Lilly And Co (NYSE:LLY) SVP Myles O’neill sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, December 10th. The shares were sold at an average price of $112.92, for a total value of $2,823,000.00. Following the completion of the transaction, the senior vice president now directly owns 26,562 shares in the company, valued at $2,999,381.04. The sale was disclosed in a document filed with the SEC, which is accessible through this link. LLY traded up $0.20 during midday trading on Thursday, reaching $114.54. The company’s stock had a trading volume of 107,165 shares, compared to its average volume of 4,102,320. The firm has a market capitalization of $121.29 billion, a P/E ratio of 26.78, a price-to-earnings-growth ratio of 1.78 and a beta of 0.31. The company has a quick ratio of 1.53, a current ratio of 1.91 and a debt-to-equity ratio of 0.83. Eli Lilly And Co has a twelve month low of $73.69 and a twelve month high of $119.84. Read more …